HLA-DRB1 and myeloid sarcoma: Furthermore, while the presence of the STK11-SNP did not influence neurological severity (as assessed by the MS severity score, MSSS), the average MSSS values were lower in patients who harbored both the STK11-SNP and the HLA-DRB1*1501 risk allele.